Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and are prescribing it for subcutaneous administration like that, even though the confusion about its status has triggered a vibrant oral capsule market for BPC in what appears for being a grey location of legality. https://ernestt000toi4.westexwiki.com/user